GlassScriptPhysician profile
Benjamin R Rodriguez
NPI 1588998645
$7,293.12
in general payments reported to CMS, 2019-2025
44 companies · $1,299 in 2025
The $1,299 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $512 · 2022: $904 · 2023: $1,542 · 2024: $3,036 · 2025: $1,299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,710 · Travel and Lodging: $1,167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,709.75 |
| Travel and Lodging | $1,167.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $1,858.57 | 2021-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Novo Nordisk INC | $958.49 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $541.49 | 2021-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $350.43 | 2021-2025 | Airsupra, Farxiga, Lokelma |
| Lilly USA, LLC | $346.11 | 2021-2024 | Mounjaro, Jardiance, Zepbound |
| Abbott Laboratories | $343.81 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Sanofi-Aventis U.S. LLC | $288.45 | 2021-2024 | |
| Dexcom, INC. | $267.95 | 2023-2025 | Dexcom G6 Transmitter |
| Novartis Pharmaceuticals Corporation | $254.81 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $249.83 | 2023-2025 | |
| Pfizer INC. | $182.55 | 2023-2025 | |
| Xeris Pharmaceuticals, INC. | $152.69 | 2023-2025 | Gvoke Hypopen, Recorlev |
| Takeda Pharmaceuticals U.S.A., INC. | $145.40 | 2023-2025 | Entyvio |
| Glaxosmithkline, LLC. | $134.38 | 2021-2025 | Trelegy Ellipta, Arexvy, Bexsero |
| Amgen INC. | $131.22 | 2023-2024 | Repatha, Evenity, Prolia |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.